1. Home
  2. TSEM vs NUVL Comparison

TSEM vs NUVL Comparison

Compare TSEM & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSEM
  • NUVL
  • Stock Information
  • Founded
  • TSEM 1993
  • NUVL 2017
  • Country
  • TSEM Israel
  • NUVL United States
  • Employees
  • TSEM N/A
  • NUVL N/A
  • Industry
  • TSEM Semiconductors
  • NUVL Biotechnology: Pharmaceutical Preparations
  • Sector
  • TSEM Technology
  • NUVL Health Care
  • Exchange
  • TSEM Nasdaq
  • NUVL Nasdaq
  • Market Cap
  • TSEM 5.8B
  • NUVL 5.6B
  • IPO Year
  • TSEM 1994
  • NUVL 2021
  • Fundamental
  • Price
  • TSEM $37.41
  • NUVL $74.48
  • Analyst Decision
  • TSEM Strong Buy
  • NUVL Strong Buy
  • Analyst Count
  • TSEM 3
  • NUVL 10
  • Target Price
  • TSEM $60.00
  • NUVL $113.10
  • AVG Volume (30 Days)
  • TSEM 804.9K
  • NUVL 511.2K
  • Earning Date
  • TSEM 05-08-2025
  • NUVL 05-08-2025
  • Dividend Yield
  • TSEM N/A
  • NUVL N/A
  • EPS Growth
  • TSEM N/A
  • NUVL N/A
  • EPS
  • TSEM 1.85
  • NUVL N/A
  • Revenue
  • TSEM $1,436,122,000.00
  • NUVL N/A
  • Revenue This Year
  • TSEM $11.90
  • NUVL N/A
  • Revenue Next Year
  • TSEM $12.51
  • NUVL N/A
  • P/E Ratio
  • TSEM $20.74
  • NUVL N/A
  • Revenue Growth
  • TSEM 0.94
  • NUVL N/A
  • 52 Week Low
  • TSEM $30.48
  • NUVL $61.80
  • 52 Week High
  • TSEM $55.31
  • NUVL $113.51
  • Technical
  • Relative Strength Index (RSI)
  • TSEM 30.16
  • NUVL 46.70
  • Support Level
  • TSEM $35.41
  • NUVL $64.75
  • Resistance Level
  • TSEM $38.68
  • NUVL $73.24
  • Average True Range (ATR)
  • TSEM 1.81
  • NUVL 3.26
  • MACD
  • TSEM -0.40
  • NUVL -0.03
  • Stochastic Oscillator
  • TSEM 20.49
  • NUVL 64.22

About TSEM Tower Semiconductor Ltd.

Tower Semiconductor Ltd is a pure-play specialty foundry that manufactures semiconductors. As a pure-play foundry, it focuses on producing integrated circuits (ICs), based on the design specifications of customers. The company's line of integrated circuits is incorporated into a range of products and markets, including consumer electronics, personal computers, communications, automotive, and industrial and medical device products. Tower produces ICs alongside wholly-owned subsidiaries through fabrication facilities located in Japan. As a complement to its technology offerings, Tower offers services that enable a quick and accurate design cycle. To further assist customers with design and technical support, an integrated team helps clients through the manufacturing cycle.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: